In the liver tissue of H22 tumor-bearing mice, the RT-PCR results showed that the mRNA expression levels of FasL and TRAIL were significantly higher in AAGL-treated mice than control mice (Supplementary Figure S3A). The gene discussed is FASLG; the disease is neoplasm.